Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

IDEX logoIDEX IEX

IDEX said net sales for Q1 2025 were $814.3 million, up 2% from the same prior year period, and organic sales decreased 1%. Diluted earnings per share attributable to IDEX were $1.26, down 21%.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. IDEX said net sales for Q1 2025 were $814.3 million, up 2% from the same prior year period, and organic sales decreased 1%. Diluted earnings per share attributable to IDEX were $1.26, down 21%.

  2. The company cited interest on borrowings to fund the Mott acquisition during Q3 2024 and the absence of discrete one-time tax benefits during Q1 2024 as factors in the decrease in diluted EPS and Adjusted diluted EPS. The effective tax rate was 23.4%, compared with 21.5% in the same prior year period.

  3. IDEX said cash flows provided by operating activities for Q1 2025 decreased $50.9 million compared with the same prior year period. The company cited higher investments in operating working capital driven by increased inventory purchases to support planned production and higher interest payments on the 4.950% Senior Notes as factors.

  4. The company repurchased 0.3 million shares for $50.0 million during Q1 2025 and said there were no share repurchases during Q1 2024. As of March 31, 2025, the amount of share repurchase authorization remaining was $489.7 million, and total dividend payments to common shareholders were $52.4 million.

Key figures

Quarter ended March 31, 2025

Revenue
$814M
Operating income
$142M
Net income
$96M
EPS
$1.26
Gross profit
$369M
Operating cash flow
$106M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q1 Net Sales $814.3 million, EPS $1.26

IDEX said net sales for Q1 2025 were $814.3 million, up 2% from the same prior year period, and organic sales decreased 1%. Diluted earnings per share attributable to IDEX were $1.26, down 21%.

Source · Based on the MD&A text of the filing

Company Explanation for EPS Decline

The company cited interest on borrowings to fund the Mott acquisition during Q3 2024 and the absence of discrete one-time tax benefits during Q1 2024 as factors in the decrease in diluted EPS and Adjusted diluted EPS. The effective tax rate was 23.4%, compared with 21.5% in the same prior year period.

Source · Based on the MD&A text of the filing

Operating Cash Flow Decreased $50.9 million

IDEX said cash flows provided by operating activities for Q1 2025 decreased $50.9 million compared with the same prior year period. The company cited higher investments in operating working capital driven by increased inventory purchases to support planned production and higher interest payments on the 4.950% Senior Notes as factors.

Source · Based on the MD&A text of the filing

Share Repurchases and Dividend Payments

The company repurchased 0.3 million shares for $50.0 million during Q1 2025 and said there were no share repurchases during Q1 2024. As of March 31, 2025, the amount of share repurchase authorization remaining was $489.7 million, and total dividend payments to common shareholders were $52.4 million.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.